<SEC-DOCUMENT>0000947871-16-000964-index.html : 20160212
<SEC-HEADER>0000947871-16-000964.hdr.sgml : 20160212
<ACCEPTANCE-DATETIME>20160212163512
ACCESSION NUMBER:		0000947871-16-000964
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20160212
DATE AS OF CHANGE:		20160212
GROUP MEMBERS:		DOMINIQUE SEMON
GROUP MEMBERS:		MERLIN NEXUS IV, L.P.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTERLEUKIN GENETICS INC
		CENTRAL INDEX KEY:			0001037649
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				943123681
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-53249
		FILM NUMBER:		161419893

	BUSINESS ADDRESS:	
		STREET 1:		135 BEAVER ST
		CITY:			WATHAM
		STATE:			MA
		ZIP:			02452
		BUSINESS PHONE:		1-781-398-0700

	MAIL ADDRESS:	
		STREET 1:		135 BEAVER ST
		CITY:			WATHAM
		STATE:			MA
		ZIP:			02452

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEDICAL SCIENCE SYSTEMS INC
		DATE OF NAME CHANGE:	19971003

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Merlin BioMed Private Equity Advisors, L.L.C.
		CENTRAL INDEX KEY:			0001429303
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		230 PARK AVE, SUITE 928
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10169
		BUSINESS PHONE:		646-227-5270

	MAIL ADDRESS:	
		STREET 1:		230 PARK AVE, SUITE 928
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10169
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>ss1399470_sc13ga.htm
<DESCRIPTION>AMENDMENT NO. 3
<TEXT>
Document 1 - file: ss1399470_sc13ga.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.B
<SEQUENCE>2
<FILENAME>ss1399470_ex99b.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ss1399470_ex99b.htm

</DOCUMENT>
</SEC-DOCUMENT>